ESCRS - Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W ;
Supplements

Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W

Supplement: Easing the Marathon Glaucoma Patient Journey with iStent inject® W

This supplement shares technical tips on taking the first step with iStent inject® W, improving the benefit to risk ratio, and improving quality of life on the glaucoma journey.

Tags: glaucoma
Latest Articles
ESCRS Research Projects Make a Difference

EPICAT study continues tradition of practice-changing clinical studies.

Read more...

Tablao Debates: Cataract-Refractive Edition

Lively debate format pairs EDOF lenses with trifocals in a dance for first prize in surgery choice.

Read more...

Phakic IOLs for Myopia and Presbyopia

Many options for patients under age 60.

Read more...

Effect of COVID-19 and Vaccine on Retinal Disease

Registry-based studies indicate risk for retinal vascular occlusions have not increased.

Read more...

Going Beyond Cataract Camps

ESCRS expanding treatment opportunities in underserved areas.

Read more...

Bridging the Gap Between Local and Global

New training programmes seek to reach hard-to-reach areas to meet growing patient needs.

Read more...

2024 Congress Draws Global Audience, Strengthens Ties

Read more...

Refractive EDOF with the Benefits of Monofocal

PureSee IOL studies indicate high patient satisfaction.

Read more...

Making the Right IOL Decisions

Use of presbyopia-correcting lenses in post-corneal refractive surgery patients requires attention to multiple considerations.

Read more...

Training to Target Global Cataract Blindness

Non-profit organisations look to innovative, scalable virtual reality training systems.

Read more...